Skin News and Research

RSS

FDA approves use for Lymphoseek to help doctors determine extent of neck and cancer

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.

16 Jun 2014

Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome

A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed a significantly increased risk of heart attack in patients with Sj-gren's syndrome (SjS), particularly in the first year following diagnosis.

13 Jun 2014

People exposed to core disgusts show higher levels of attention

We know it too well. We are watching a horror film and the antagonist is about to maim a character; we ball up, get ready for the shot and instead of turning away, we lean forward in the chair, then flinch and cover our eyes - Jason strikes again! But what is going on in our body that drives us to this reaction, and why do we engage in it so readily? Recent research published in the Journal of Communication found that people exposed to core disgusts (blood, guts, body products) showed higher levels of attention the more disgusting the content grew even though they had negative reactions to the content.

13 Jun 2014

Sutter Health invests $11.5M to install patient safety equipment across Northern California

Today, not-for-profit Sutter Health announces an $11.5 million commitment to install overhead patient lifts at 19 intensive care units and acute rehabilitation centers across its Northern California network.

12 Jun 2014

Tips to protect child's skin during summer

Marty Visscher, Ph.D., Director, Skin Sciences Program at Cincinnati Children's Hospital Medical Center, explains that some parents do not understand the dangers of prolonged sun exposure on their child's skin.

12 Jun 2014

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.

12 Jun 2014

UTMB surgeon awarded prestigious Tanner-Vandeput-Boswick Burn Prize

Dr. David Herndon of the University of Texas Medical Branch will receive an international award for his contributions to the field of burn care research and innovations in improving the care of burn survivors.

11 Jun 2014

Health tips for global travellers

Nothing ruins a summer vacation faster than getting sick. "Remember that most diseases are transmitted by food, water and insects," says John A. Sellick, Jr., DO, University at Buffalo associate professor of medicine and hospital epidemiologist at Veterans Affairs Western New York Healthcare System. "So get vaccinated, keep insects off you as much as possible and be careful with what you put in your mouth."

11 Jun 2014

Molecular mechanisms regulating tumour initiation in skin SCC uncovered

Advanced online publication in Nature: Researchers at the Université libre de Bruxelles, ULB uncover the molecular mechanisms regulating tumour initiation and cancer stem cells functions in skin squamous cell carcinoma.

11 Jun 2014

ClarityMD effective in clearing acne without irritation

Envy Medical, Inc., a leader in professional skincare products and services, is excited to announce the publication of a new study in the June issue of the Journal of Drugs in Dermatology (JDD) proving the superior efficacy of its highly innovative acne system – ClarityMD.

11 Jun 2014

Knowing summer allergies

As if a runny nose and red eyes weren't enough to ruin your warm weather look, summer allergies can gift you with even more than you've bargained for this year. In fact, some unusual symptoms can leave you looking like you lost a round in a boxing ring.

11 Jun 2014

Study presents oxytocin as latest treatment target for age-related muscle wasting

Researchers at the University of California, Berkeley, have discovered that oxytocin -- a hormone associated with maternal nurturing, social attachments, childbirth and sex -- is indispensable for healthy muscle maintenance and repair, and that in mice, it declines with age.

11 Jun 2014

New biometric wearable devices use scattered light to monitor glucose levels and pulse

Monitoring a patient's vital signs and other physiological parameters is a standard part of medical care, but, increasingly, health and fitness-minded individuals are looking for ways to easily keep their own tabs on these measurements. Enter the biometric watch.

11 Jun 2014

EU-funded project aims to identify potential new targets for cancer therapy

Targeted therapies have revolutionised the treatment of cancer since they were first introduced. Amongst the first medications approved in Europe, was the breast cancer drug Herceptin, which was approved in 2000. Then, the drug Glivec, was initially introduced to treat a certain form of leukaemia, and approved in 2001. Targeted therapies specifically inhibit molecules within so-called signalling pathways that usually control cell growth, death and differentiation. If they are altered, for example falsely inactivated or activated, the cells may start growing in an uncontrolled manner.

11 Jun 2014

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced that it has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections.

10 Jun 2014

electroCore's non-invasive vagus nerve stimulation therapy reduces cluster headache attacks

In a multi-center, randomized, trial across Europe, electroCore's non-invasive vagus nerve stimulation (nVNS) therapy was found to meet its primary endpoint of statistical significance in reducing the number of cluster headache attacks when compared with the standard of care.

10 Jun 2014

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment.

10 Jun 2014

Lifestyle changes, natural supplements can help women fight weight gain during menopause

Menopause, which tends to occur in midlife, is often known for causing weight gain. Menopausal weight gain is frequently caused by the hormonal changes that occur as the ovaries slow their production of estrogen and progesterone.

9 Jun 2014

Celsus’ expert highlights serious side effects of topical corticosteroids

A 2013 Mayo Clinic study involving more than 140,000 patients revealed that skin disorders are the most common nonacute reason Americans seek health care.

9 Jun 2014

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Stunning scientific images of blood, brain, bacteria, viruses and more, enlarged by as much as 50,000 times, are on display in an exhibit called "Life: Magnified," on view through November 2014 at Washington Dulles International Airport's Gateway Gallery.

9 Jun 2014

Skin News and Research

FDA approves use for Lymphoseek to help doctors determine extent of neck and cancer

Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome

People exposed to core disgusts show higher levels of attention

Sutter Health invests $11.5M to install patient safety equipment across Northern California

Tips to protect child's skin during summer

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

UTMB surgeon awarded prestigious Tanner-Vandeput-Boswick Burn Prize

Health tips for global travellers

Molecular mechanisms regulating tumour initiation in skin SCC uncovered

ClarityMD effective in clearing acne without irritation

Knowing summer allergies

Study presents oxytocin as latest treatment target for age-related muscle wasting

New biometric wearable devices use scattered light to monitor glucose levels and pulse

EU-funded project aims to identify potential new targets for cancer therapy

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

electroCore's non-invasive vagus nerve stimulation therapy reduces cluster headache attacks

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Lifestyle changes, natural supplements can help women fight weight gain during menopause

Celsus’ expert highlights serious side effects of topical corticosteroids

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News